Medical Oncologist, PhD, Oncology Center, Hospital Moinhos de Vento and Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Professor of Medicine UFRGS
ESMO election for president 2027-2028:
@Prof_Nadia_H has been committed with education, equal opportunity, and women empowerment; she can make a huge difference in Oncology!
As a Brazilian medical oncologist, I support prof Nadia Harbeck for President of @myESMO!
Estamos em contagem regressiva: o ESMO Summit Latin America 2024 começa em 3 dias! Já destacamos o Comitê Científico do evento e os speakers internacionais. Hoje, é dia de conhecer os palestrantes nacionais.
Além das atualizações científicas em diversos tumores e os debates sobre pesquisa e educação, um dos destaques da programação do ESMO Summit Latin America 2024 será a sessão “Liderança Feminina na Oncologia”.
Elacestrant approved for esr1m mbc. A journey that started from the phase 1 trial here at @UTHealthSAMDA with the collaboration of Aditya Bardia to the phase 3 EMERALD trial showing significant improvement compared with soc et. @Stemline@aftimosp
This week another edition of the @SABCSSanAntonio is taking place in Texas, USA. The symposium has the participation of researchers, academics and physicians from more than 80 countries, including several members of LACOG and GBECAM.
I am honoured to be a candidate for the position of ESMO Director of Membership. Elections will take place between June 1st and June 27th, 2022. @myESMO
.@GustaveRoussy is investing a lot in young scientists through starting grants, mentoring and infrastructure.
If you are interested in running research on epigenetics in an environment that fully integrates basic and clinical research, you could join the team of Nataliya.
We have lost an icon in Oncology today. His mentorship has guided many of us and he always brought the best in all of us. We will deeply miss his leadership, his brilliance and and his passion for bringing better therapies for patients. Jose, we will deliver on what you started.